VANCOUVER, BRITISH COLUMBIA--(Marketwire - November 06, 2007) - EnWave Corporation (TSX VENTURE: ENW)(FRANKFURT: E4U) (“EnWave” or “the Company”) is pleased to report that, following a successful engineering test period at EnWave’s Vancouver laboratory, the Company’s bioREV prototype is to be relocated to San Jose, California to begin a rigorous scientific testing program.
